We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current FBT market cap is 1.35B. The company's latest EPS is USD 2.5683 and P/E is 64.63.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 7.55M | 5.15M | 6.33M | 4.24M | 3.48M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | 300.88M | 204.62M | -71.36M | -94.77M | 20.93M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.8B | 2.04B | 1.71B | 1.48B | 1.29B |
| Total Liabilities | 1.45M | 2.03M | 1.38M | 1.11M | 2.26M |
| Total Equity | 1.8B | 2.04B | 1.71B | 1.48B | 1.29B |
| Market Cap | 1.35B |
| Price to Earnings Ratio | 64.63 |
| Price to Sales Ratio | 389.17 |
| Price to Cash Ratio | 1.81k |
| Price to Book Ratio | 1.05 |
| Dividend Yield | - |
| Shares Outstanding | 8.15M |
| Average Volume (1 week) | 45.37k |
| Average Volume (1 Month) | 23.1k |
| 52 Week Change | 6.57% |
| 52 Week High | 166.85 |
| 52 Week Low | 130.2701 |
| Spread (Intraday) | 18.81 (10.78%) |
| Company Name | First Trust NYSE Arca Biotechnology Index Fund |
| Address |
155 federal st boston, massachusetts 02110 |
| Website | https:// |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
